Cargando…

Ki67 and breast cancer mortality in women with invasive breast cancer

BACKGROUND: The percentage of cells staining positive for Ki67 is sometimes used for decision-making in patients with early invasive breast cancer (IBC). However, there is uncertainty regarding the most appropriate Ki67 cut points and the influence of interlaboratory measurement variability. We exam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Probert, Jake, Dodwell, David, Broggio, John, Charman, Jackie, Dowsett, Mitch, Kerr, Amanda, McGale, Paul, Taylor, Carolyn, Darby, Sarah C, Mannu, Gurdeep S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500622/ https://www.ncbi.nlm.nih.gov/pubmed/37567612 http://dx.doi.org/10.1093/jncics/pkad054

Ejemplares similares

Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study
por: Taylor, Carolyn, et al.
Publicado: (2023)

Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality
por: Kerr, Amanda J., et al.
Publicado: (2022)

Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study
por: Mannu, Gurdeep S, et al.
Publicado: (2020)

Making progress in early breast cancer: Taking time or accepting risk?
por: Mannu, Gurdeep S., et al.
Publicado: (2017)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
por: Nielsen, Torsten O, et al.
Publicado: (2020)

Endocrine therapy in the years following a diagnosis of breast cancer: A proof of concept study using the primary care prescription database linked to cancer registration data
por: Emanuel, Gabrielle, et al.
Publicado: (2019)

Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer
por: Burcombe, Russell, et al.
Publicado: (2006)

Ki-67 biomarker in breast cancer of Indian women
por: Patil, Amit V., et al.
Publicado: (2011)

Interobserver Variability of Ki-67 Measurement in Breast Cancer
por: Chung, Yul Ri, et al.
Publicado: (2016)

Ki-67, an elusive marker in the prognosis of breast cancer
por: Sood, Neelam
Publicado: (2019)

Association of Ki-67 With Clinicopathological Factors in Breast Cancer
por: ., Nishit, et al.
Publicado: (2021)

Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer
por: Henson, K E, et al.
Publicado: (2013)

UK NEQAS ICC & ISH Ki-67 Data Reveal Differences in Performance of Primary Antibody Clones
por: Parry, Suzanne, et al.
Publicado: (2021)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
por: Fasanella, S, et al.
Publicado: (2011)

A novel model for Ki67 assessment in breast cancer
por: Romero, Quinci, et al.
Publicado: (2014)

Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer
por: Davey, Matthew G., et al.
Publicado: (2021)

Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes
por: Holt, Francesca, et al.
Publicado: (2023)

High‐throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium
por: Abubakar, Mustapha, et al.
Publicado: (2016)

Quantum Dots-Based Quantitative and In Situ Multiple Imaging on Ki67 and Cytokeratin to Improve Ki67 Assessment in Breast Cancer
por: Yuan, Jing Ping, et al.
Publicado: (2015)

Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
por: Boyaci, Ceren, et al.
Publicado: (2021)

Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen?
por: Choi, Soon Bo, et al.
Publicado: (2022)

Breast cancer Ki-67 expression prediction by digital breast tomosynthesis radiomics features
por: Tagliafico, Alberto Stefano, et al.
Publicado: (2019)

Ki67 immunostaining in primary breast cancer: pathological and clinical associations.
por: Bouzubar, N., et al.
Publicado: (1989)

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer.
por: Railo, M., et al.
Publicado: (1993)

New Insight into Ki67 Expression at the Invasive Front in Breast Cancer
por: Gong, Peng, et al.
Publicado: (2013)

An Interobserver Reproducibility Analysis of Ki67 Visual Assessment in Breast Cancer
por: Shui, Ruohong, et al.
Publicado: (2015)

Prognostic and predictive value of Ki-67 in triple-negative breast cancer
por: Wang, Wei, et al.
Publicado: (2016)

Associations Between PET Parameters and Expression of Ki-67 in Breast Cancer()()()
por: Surov, Alexey, et al.
Publicado: (2018)

Assessment of Ki-67 as a potential biomarker in patients with breast cancer
por: Ragab, Halla Mohamed, et al.
Publicado: (2018)

The prognostic and predictive potential of Ki-67 in triple-negative breast cancer
por: Zhu, Xiuzhi, et al.
Publicado: (2020)

Clinical validity and clinical utility of Ki67 in early breast cancer
por: Kreipe, Hans, et al.
Publicado: (2022)

A Preliminary Analysis of Ki-67 Expression in Breast Cancer in the Caribbean
por: Jogie, Joshua A, et al.
Publicado: (2023)

Cardiac mortality after radiotherapy, chemotherapy and endocrine therapy for breast cancer: Cohort study of 2 million women from 57 cancer registries in 22 countries
por: Henson, Katherine E., et al.
Publicado: (2020)

Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer
por: Abubakar, Mustapha, et al.
Publicado: (2019)

A comparative study between Ki67 positive versus Ki67 negative females with breast cancer: Cross sectional study
por: Bahaddin, Mowafak Masoud
Publicado: (2020)

The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment
por: Eshwaraiah, Mallikarjuna Siraganahalli, et al.
Publicado: (2023)

Ki-67 expression in luminal type breast cancer and its association with the clinicopathology of the cancer
por: YUAN, PENG, et al.
Publicado: (2016)

International Variation in Criteria for Internal Mammary Chain Radiotherapy
por: Duane, F.K., et al.
Publicado: (2019)

Ki-67 as a Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Kim, Kwan Il, et al.
Publicado: (2014)

The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes
por: Stathopoulos, George P., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a1o5g2m7ge3ert0ban9kg3gef9